C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study

OBJECTIVE: AML is a heterogeneous disease both in genomic and proteomic backgrounds, and variable outcomes may appear in the same cytogenetic risk group. Therefore, it is still necessary to identify new antigens that contribute to diagnostic information and to refine the current risk stratification....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Wang, Jinghua, Wang, Weida, Chen, Hao, Li, Wenmin, Huang, Tian, Zhang, Weiya, Ling, Wei, Lai, Peilong, Wang, Yulian, Geng, Suxia, Li, Minming, Du, Xin, Weng, Jianyu
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979301/
https://ncbi.nlm.nih.gov/pubmed/33778076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6643948
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars